Brenntag, the global market leader in chemicals and ingredients distribution, announced the opening of its new Life Sciences Innovation & Application Center in Shanghai, strengthening its commitment to supporting customers and suppliers in China and Hong Kong with advanced technical capabilities and closer access …
GCE Global Solutions announced the launch of PayrollCalculator.AI, a next-generation global payroll intelligence platform powered by augmented intelligence. More than a traditional calculator, PayrollCalculator.AI serves as the strategic entry point into the GCE ecosystem — enabling organizations to move seamlessly f…
CHIME International, through its UK chapter, welcomed the announcement of forthcoming professional requirements for NHS digital health professionals, marking an important milestone in strengthening the digital workforce across the United Kingdom. While formal timelines and detailed guidance are expected to be confirme…
Viva Biotech optimizes the Proteina-Complexa model in advancing the design of mini-binders targeting ActRIIA, a receptor critical in muscle wasting and lean mass imbalance, aiming to accelerate the discovery of novel therapeutics with AI-driven designs with NVIDIA technology. The collaboration highlights Viva Biote…
More than one-third of high-risk participants reduced their risk profile in one year, according to a new impact report from Navigate Wellbeing Solutions released this week at The Conference Board's 26th Annual Employee Health Care Conference in New York City. Movement out of high-risk categories is one of the clearest…
GenScript announced the official opening of its first European mRNA production site in Delft, the Netherlands, marking a significant expansion of the company's global mRNA platform and reinforcing Europe as a core pillar of its integrated R&D and production network. The Delft facility strengthens GenScript's tran…
Andel announced the launch of its app and medication platform, giving companies a new way to make GLP-1s an accessible employee benefit. The company is excited to announce that Eli Lilly and Company's newly-approved Zepbound® KwikPen® will be the inaugural medication available on the Andel platform. Andel offers a un…
LabConnect, a leading provider of technology-driven central laboratory services and functional service provider solutions for clinical trials, announced the grand opening of its new facility in Wuxi, China. As clinical trials become increasingly global and complex, sponsors are seeking laboratory partners that can pro…
Antheia, the advanced biosynthesis company delivering 21st-century pharmaceutical manufacturing and innovation, announced it has expanded the scope of its second project agreement with the Biopharmaceutical Manufacturing Preparedness Consortium (BioMaP-Consortium), securing an additional $9 million. The additional fun…
Atrium Therapeutics, Inc as a newly independent, publicly traded company dedicated to delivering RNA therapeutics directly to the heart to transform care for people living with rare, life-threatening genetic cardiomyopathies. Atrium Therapeutics was established in connection with Avidity Biosciences, Inc.'s acquisitio…
Page 6 of 54